Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: Upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole

✍ Scribed by C. Skedgel; D. Rayson; R. Dewar; T. Younis

• Book ID: 113506848
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 694 KB
• Volume: 16
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/j.breast.2006.12.002